ebselen has been researched along with Multiple Myeloma in 1 studies
ebselen : A benzoselenazole that is 1,2-benzoselenazol-3-one carrying an additional phenyl substituent at position 2. Acts as a mimic of glutathione peroxidase.
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, L | 1 |
| Zhou, L | 1 |
| Du, J | 1 |
| Li, M | 1 |
| Qian, C | 1 |
| Cheng, Y | 1 |
| Peng, Y | 1 |
| Xie, J | 1 |
| Wang, D | 1 |
1 other study available for ebselen and Multiple Myeloma
| Article | Year |
|---|---|
Induction of apoptosis in human multiple myeloma cell lines by ebselen via enhancing the endogenous reactive oxygen species production.
Topics: Apoptosis; Azoles; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Survival; Humans; Isoindoles; | 2014 |